Viveve Medical Inc Share Price Nasdaq
Equities
CA92852W2040
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc. | CI |
2023 | Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index | CI |
Sales 2020 | 5.48M 457M | Sales 2021 | 6.43M 536M | Capitalization | 12.09M 1.01B |
---|---|---|---|---|---|
Net income 2020 | -21M -1.75B | Net income 2021 | -22M -1.84B | EV / Sales 2020 | 1.77 x |
Net cash position 2020 | 530K 44.22M | Net cash position 2021 | 13.49M 1.13B | EV / Sales 2021 | -0.22 x |
P/E ratio 2020 |
-0.28
x | P/E ratio 2021 |
-0.43
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Jim Robbins
DFI | Director of Finance/CFO | 60 | 01/14/01 |
Doug Massey
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Gary Kaiser
SAM | Sales & Marketing | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Presnell
BRD | Director/Board Member | 55 | 28/20/28 |
1st Jan change | Capi. | |
---|---|---|
+7.93% | 219B | |
+7.53% | 183B | |
+15.20% | 136B | |
+27.02% | 107B | |
-1.14% | 63.07B | |
+7.23% | 52.55B | |
+12.58% | 51.28B | |
+1.61% | 41.21B | |
+5.32% | 36.43B |